These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33478061)
1. A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects. Liu Z; Yu Z; Yu S; Zhu C; Dong M; Mao W; Hu J; Prorok M; Su R; Dai Q Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33478061 [No Abstract] [Full Text] [Related]
2. Con-T[M8Q] potently attenuates the expression and development of morphine tolerance in mice. Ren B; Zhou Z; Liu Z; Li B; Ou J; Dai Q Neurosci Lett; 2015 Jun; 597():38-42. PubMed ID: 25896730 [TBL] [Abstract][Full Text] [Related]
3. Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice. Wei J; Dong M; Xiao C; Jiang F; Castellino FJ; Prorok M; Dai Q Neurosci Lett; 2006 Sep; 405(1-2):137-41. PubMed ID: 16859831 [TBL] [Abstract][Full Text] [Related]
4. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides. Sheng Z; Dai Q; Prorok M; Castellino FJ Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620 [TBL] [Abstract][Full Text] [Related]
5. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B. Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876 [TBL] [Abstract][Full Text] [Related]
6. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors. Sheng Z; Prorok M; Castellino FJ Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135 [TBL] [Abstract][Full Text] [Related]
7. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Donevan SD; McCabe RT Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Klein RC; Galdzicki Z; Castellino FJ Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277 [TBL] [Abstract][Full Text] [Related]
9. Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors. Balsara R; Li N; Weber-Adrian D; Huang L; Castellino FJ Neuropharmacology; 2012 Jun; 62(7):2227-38. PubMed ID: 22306487 [TBL] [Abstract][Full Text] [Related]
10. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Xiao C; Huang Y; Dong M; Hu J; Hou S; Castellino FJ; Prorok M; Dai Q Neuropeptides; 2008; 42(5-6):601-9. PubMed ID: 18992939 [TBL] [Abstract][Full Text] [Related]
11. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. Klein RC; Prorok M; Galdzicki Z; Castellino FJ J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724 [TBL] [Abstract][Full Text] [Related]